You are currently on the new version of our website. Access the old version .

3,838 Results Found

  • Article
  • Open Access
2 Citations
3,102 Views
18 Pages

Background and objective: The symptoms of most neurodegenerative diseases, including Parkinson’s disease (PD), usually do not occur until substantial neuronal loss occurs. This makes the process of early diagnosis very challenging. Hence, this...

  • Brief Report
  • Open Access
8 Citations
4,059 Views
12 Pages

Impact of COVID-19 Pandemic on (Health) Care Situation of People with Parkinson’s Disease in Germany (Care4PD)

  • Odette Fründt,
  • Anne-Marie Hanff,
  • Tobias Mai,
  • Christiane Kirchner,
  • Emma Bouzanne des Mazery,
  • Ali Amouzandeh,
  • Carsten Buhmann,
  • Rejko Krüger and
  • Martin Südmeyer

31 December 2021

The Care4PD study examined the impact of the COVID-19 pandemic on the care situation of people (PwP) with Parkinson’s disease in Germany. A comprehensive, nationwide, anonymous questionnaire for PwP was distributed by the members’ journal...

  • Article
  • Open Access
102 Citations
8,046 Views
24 Pages

The Therapeutic Implications of Tea Polyphenols against Dopamine (DA) Neuron Degeneration in Parkinson’s Disease (PD)

  • Zhi Dong Zhou,
  • Shao Ping Xie,
  • Wuan Ting Saw,
  • Patrick Ghim Hoe Ho,
  • Hong Yan Wang,
  • Lei Zhou,
  • Yi Zhao and
  • Eng King Tan

16 August 2019

Accumulative evidence indicated that the pathologically accumulated metal ions (iron species and Mn3+) and abnormally up-regulated monoamine oxidase B (MAOB) activity induced oxidation of endogenous dopamine (DA) can lead to mitochondria impairment,...

  • Article
  • Open Access
3 Citations
2,171 Views
11 Pages

Utilization of MANAGE-PD Tool in a Real-World Setting in Germany: A Cross-Sectional Study

  • Martin Südmeyer,
  • David J. Pedrosa,
  • Frank Siebecker,
  • Carolin Arlt,
  • Jaakko J. Kopra and
  • Wolfgang H. Jost

MANAGE-PD is a validated, web-based tool to assist physicians in identifying patients with Parkinson’s disease (PD) whose symptoms are inadequately controlled by oral medication. Also, a modified patient version of MANAGE-PD (Parkinson Check) i...

  • Article
  • Open Access
13 Citations
2,890 Views
13 Pages

Parkinson’s disease: Parkinson’s disease (PD) is the second-most common neurodegenerative disease, affecting at least 0.3% of the worldwide population and over 3% of those over 80 years old. According to recent research (2018), in 2016, 6...

  • Review
  • Open Access
9 Citations
3,224 Views
11 Pages

Ambiental Factors in Parkinson’s Disease Progression: A Systematic Review

  • Anastasia Bougea,
  • Nikolas Papagiannakis,
  • Athina-Maria Simitsi,
  • Elpida Panagiotounakou,
  • Chrysa Chrysovitsanou,
  • Efthalia Angelopoulou,
  • Christos Koros and
  • Leonidas Stefanis

5 February 2023

Background and Objectives: So far, there is little evidence of the ambient effect on motor and non-motor symptoms of Parkinson’s Disease (PD). This systematic review aimed to determine the association between ambiental factors and the progressi...

  • Editorial
  • Open Access
4 Citations
3,680 Views
3 Pages

11 September 2020

Neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD) and Huntington’s disease (HD), severely impact the function of neuronal cells in the brain and have devastating consequences on the quality of lif...

  • Review
  • Open Access
14 Citations
5,288 Views
29 Pages

Cyclophilin D in Mitochondrial Dysfunction: A Key Player in Neurodegeneration?

  • Gabriele Coluccino,
  • Valentina Pia Muraca,
  • Alessandra Corazza and
  • Giovanna Lippe

18 August 2023

Mitochondrial dysfunction plays a pivotal role in numerous complex diseases. Understanding the molecular mechanisms by which the “powerhouse of the cell” turns into the “factory of death” is an exciting yet challenging task th...

  • Review
  • Open Access
7 Citations
4,528 Views
15 Pages

Migraine, Tension-Type Headache and Parkinson’s Disease: A Systematic Review and Meta-Analysis

  • Efthalia Angelopoulou,
  • Andreas Nikolaos Papadopoulos,
  • Nikolaos Spantideas and
  • Anastasia Bougea

20 November 2022

Background and Objectives: The relationship between migraine and tension-type headache (TTH) with Parkinson’s disease (PD) is controversial, while a common pathophysiological link remains obscure. The aim of this systematic review is to investi...

  • Review
  • Open Access
10 Citations
10,986 Views
32 Pages

Parkinson’s disease (PD) is considered the second most common neurodegenerative disease worldwide; treating this disease remains quite challenging. Environmental and genetic factors may play a role in the pathophysiology of PD. α-synuclei...

  • Review
  • Open Access
58 Citations
13,289 Views
22 Pages

Parkinson’s Disease: A Complex Interplay of Mitochondrial DNA Alterations and Oxidative Stress

  • Sarah Ciccone,
  • Emiliano Maiani,
  • Giovanna Bellusci,
  • Marc Diederich and
  • Stefania Gonfloni

24 January 2013

Parkinson’s disease (PD) is one of the most common age-related neurodegenerative diseases. This pathology causes a significant loss of dopaminergic neurons in the Substantia Nigra. Several reports have claimed a role of defective nuclear and mitochon...

  • Article
  • Open Access
6 Citations
2,430 Views
12 Pages

GATA3 as a Blood-Based RNA Biomarker for Idiopathic Parkinson’s Disease

  • Shubhra Acharya,
  • Andrew I. Lumley,
  • Lu Zhang,
  • Mélanie Vausort,
  • Yvan Devaux and
  • on behalf of the NCER-PD Consortium

Finding novel biomarkers for Parkinson’s disease (PD) is crucial for early disease diagnosis, severity assessment and identifying novel disease-modifying drug targets. Our study aimed at investigating the GATA3 mRNA levels in whole blood sample...

  • Review
  • Open Access
18 Citations
5,455 Views
18 Pages

Extracellular Vesicles as Biomarkers for Parkinson’s Disease: How Far from Clinical Translation?

  • Alice Gualerzi,
  • Silvia Picciolini,
  • Marzia Bedoni,
  • Franca Rosa Guerini,
  • Mario Clerici and
  • Cristina Agliardi

17 January 2024

Parkinson’s disease (PD) is a neurodegenerative disorder affecting about 10 million people worldwide with a prevalence of about 2% in the over-80 population. The disease brings in also a huge annual economic burden, recently estimated by the Mi...

  • Review
  • Open Access
64 Citations
14,038 Views
36 Pages

Technologies for Assessment of Motor Disorders in Parkinson’s Disease: A Review

  • Qi Wei Oung,
  • Hariharan Muthusamy,
  • Hoi Leong Lee,
  • Shafriza Nisha Basah,
  • Sazali Yaacob,
  • Mohamed Sarillee and
  • Chia Hau Lee

31 August 2015

Parkinson’s Disease (PD) is characterized as the commonest neurodegenerative illness that gradually degenerates the central nervous system. The goal of this review is to come out with a summary of the recent progress of numerous forms of sensors and...

  • Review
  • Open Access
109 Citations
14,267 Views
16 Pages

Postural Instability in Parkinson’s Disease: A Review

  • Bhavana Palakurthi and
  • Sindhu Preetham Burugupally

18 September 2019

Parkinson’s disease (PD) is a heterogeneous progressive neurodegenerative disorder, which typically affects older adults; it is predicted that by 2030 about 3% of the world population above 65 years of age is likely to be affected. At present,...

  • Article
  • Open Access
35 Citations
4,819 Views
15 Pages

Neuropsychiatric Symptoms in Parkinson’s Disease Patients Are Associated with Reduced Health-Related Quality of Life and Increased Caregiver Burden

  • Hannah von Eichel,
  • Johanne Heine,
  • Florian Wegner,
  • Sophia Rogozinski,
  • Stephanie Stiel,
  • Adrian Groh,
  • Lea Krey,
  • Günter U. Höglinger and
  • Martin Klietz

11 January 2022

Parkinson’s disease (PD) is a progressive neurodegenerative disorder resulting in reduced health-related quality of life (HR-QoL) of people with PD (PwP) and their caregivers. Furthermore, there is an accumulating burden on caregivers of patien...

  • Article
  • Open Access
8 Citations
4,193 Views
15 Pages

LC-MS/MS Determination of Modified Nucleosides in The Urine of Parkinson’s Disease and Parkinsonian Syndromes Patients

  • Paulina Gątarek,
  • Joanna Kałużna-Czaplińska,
  • Małgorzata Pawełczyk,
  • Karol Jastrzębski,
  • Joanna Giebułtowicz,
  • Andrzej Głąbiński and
  • Barbara Bobrowska-Korczak

27 October 2020

Epigenetic modifications play a key role in gene regulation and expression and are involved in numerous cellular processes. Due to the limited research on nucleosides in Parkinson’s disease (PD), it is very important to consider epigenetic fact...

  • Article
  • Open Access
9 Citations
3,227 Views
14 Pages

The Genetic Basis of Probable REM Sleep Behavior Disorder in Parkinson’s Disease

  • Santiago Perez-Lloret,
  • Guenson Chevalier,
  • Sofia Bordet,
  • Hanny Barbar,
  • Francisco Capani,
  • Lucas Udovin and
  • Matilde Otero-Losada

Patients with Parkinson’s Disease (PD) experience REM sleep behavior disorder (RBD) more frequently than healthy controls. RBD is associated with torpid disease evolution. To test the hypothesis that differential genetic signatures might contri...

  • Review
  • Open Access
14 Citations
5,722 Views
15 Pages

Immunotherapy for Parkinson’s Disease and Alzheimer’s Disease: A Promising Disease-Modifying Therapy

  • Anns Mahboob,
  • Hasan Ali,
  • AlJazi AlNaimi,
  • Mahmoud Yousef,
  • Mlaak Rob,
  • Nawaf Ahmad Al-Muhannadi,
  • Degiri Kalana Lasanga Senevirathne and
  • Ali Chaari

12 September 2024

Alzheimer’s disease (AD) and Parkinson’s disease (PD) are two neurodegenerative diseases posing a significant disease burden due to their increasing prevalence and socio-economic cost. Traditional therapeutic approaches for these diseases...

  • Article
  • Open Access
868 Views
34 Pages

Stimulus-Evoked Brain Signals for Parkinson’s Detection: A Comprehensive Benchmark Performance Analysis on Cross-Stimulation and Channel-Wise Experiments

  • Krishna Patel,
  • Rajendra Gad,
  • Marissa Lourdes de Ataide,
  • Narayan Vetrekar,
  • Teresa Ferreira and
  • Raghavendra Ramachandra

Parkinson’s disease (PD) is a progressive neurodegenerative disorder that affects both motor and cognitive functions, often resulting in misdiagnosis during its early stages. The condition severely impacts daily living, diminishing an individua...

  • Review
  • Open Access
284 Citations
18,510 Views
22 Pages

Manganese-Induced Parkinsonism and Parkinson’s Disease: Shared and Distinguishable Features

  • Gunnar F. Kwakye,
  • Monica M.B. Paoliello,
  • Somshuvra Mukhopadhyay,
  • Aaron B. Bowman and
  • Michael Aschner

Manganese (Mn) is an essential trace element necessary for physiological processes that support development, growth and neuronal function. Secondary to elevated exposure or decreased excretion, Mn accumulates in the basal ganglia region of the brain...

  • Review
  • Open Access
19 Citations
8,213 Views
40 Pages

Metabolic Features of Brain Function with Relevance to Clinical Features of Alzheimer and Parkinson Diseases

  • David Allan Butterfield,
  • Maria Favia,
  • Iolanda Spera,
  • Annalisa Campanella,
  • Martina Lanza and
  • Alessandra Castegna

30 January 2022

Brain metabolism is comprised in Alzheimer’s disease (AD) and Parkinson’s disease (PD). Since the brain primarily relies on metabolism of glucose, ketone bodies, and amino acids, aspects of these metabolic processes in these disorders&mda...

  • Review
  • Open Access
73 Citations
6,782 Views
16 Pages

Autophagy in Parkinson’s Disease

  • Lior Nechushtai,
  • Dan Frenkel and
  • Ronit Pinkas-Kramarski

22 September 2023

Parkinson’s disease (PD) is a devastating disease associated with accumulation of α-synuclein (α-Syn) within dopaminergic neurons, leading to neuronal death. PD is characterized by both motor and non-motor clinical symptoms. Several...

  • Review
  • Open Access
12 Citations
6,415 Views
9 Pages

A subset of patients with a demyelinating disease suffer from concurrent cervical spondylotic myelopathy, both of which evince similar symptomatology. Differentiating the cause of these symptoms is challenging, and little research has been done on pa...

  • Review
  • Open Access
12 Citations
3,593 Views
9 Pages

In contrast to motor symptoms, non-motor symptoms in Parkinson’s disease (PD) are often poorly recognized and inadequately treated. Fatigue is one of the most common non-motor symptoms in PD and affects a broad range of everyday activities, causes di...

  • Review
  • Open Access
5 Citations
3,554 Views
15 Pages

Imaging Markers in Genetic Forms of Parkinson’s Disease

  • Amgad Droby,
  • Avner Thaler and
  • Anat Mirelman

16 August 2023

Parkinson’s disease (PD) is a complex neurodegenerative disorder characterized by motor symptoms such as bradykinesia, rigidity, and resting tremor. While the majority of PD cases are sporadic, approximately 15–20% of cases have a genetic...

  • Review
  • Open Access
11 Citations
4,902 Views
22 Pages

Parkin beyond Parkinson’s Disease—A Functional Meaning of Parkin Downregulation in TDP-43 Proteinopathies

  • Katarzyna Gaweda-Walerych,
  • Emilia Jadwiga Sitek,
  • Ewa Narożańska and
  • Emanuele Buratti

1 December 2021

Parkin and PINK1 are key regulators of mitophagy, an autophagic pathway for selective elimination of dysfunctional mitochondria. To this date, parkin depletion has been associated with recessive early onset Parkinson’s disease (PD) caused by lo...

  • Review
  • Open Access
141 Citations
43,996 Views
26 Pages

The Role of Ketogenic Diet in the Treatment of Neurological Diseases

  • Damian Dyńka,
  • Katarzyna Kowalcze and
  • Agnieszka Paziewska

24 November 2022

Over a hundred years of study on the favourable effect of ketogenic diets in the treatment of epilepsy have contributed to a long-lasting discussion on its potential influence on other neurological diseases. A significant increase in the number of sc...

  • Article
  • Open Access
9 Citations
3,767 Views
10 Pages

Frequency of Parkinson’s Disease Genes and Role of PARK2 in Amyotrophic Lateral Sclerosis: An NGS Study

  • Veria Vacchiano,
  • Anna Bartoletti-Stella,
  • Giovanni Rizzo,
  • Patrizia Avoni,
  • Piero Parchi,
  • Fabrizio Salvi,
  • Rocco Liguori and
  • Sabina Capellari

22 July 2022

Amyotrophic lateral sclerosis (ALS) and Alzheimer’s disease (AD) patients show a higher prevalence of Lewy body disease than the general population. Additionally, parkinsonian features were found in about 30% of ALS patients. We aimed to explor...

  • Review
  • Open Access
37 Citations
6,593 Views
20 Pages

Neuroinflammation and Autophagy in Parkinson’s Disease—Novel Perspectives

  • Danail Minchev,
  • Maria Kazakova and
  • Victoria Sarafian

30 November 2022

Parkinson’s disease (PD) is the second most prevalent neurodegenerative disorder. It is characterized by the accumulation of α-Synuclein aggregates and the degeneration of dopaminergic neurons in substantia nigra in the midbrain. Although...

  • Review
  • Open Access
14 Citations
17,404 Views
17 Pages

In light of the unsuccessful traditional therapies for Parkinson’s disease (PD) overmany years, there is an unmet need for the development of novel therapies to alleviate the symptoms of PD retardation or halt the progression of the disease its...

  • Article
  • Open Access
120 Citations
8,411 Views
15 Pages

GaborPDNet: Gabor Transformation and Deep Neural Network for Parkinson’s Disease Detection Using EEG Signals

  • Hui Wen Loh,
  • Chui Ping Ooi,
  • Elizabeth Palmer,
  • Prabal Datta Barua,
  • Sengul Dogan,
  • Turker Tuncer,
  • Mehmet Baygin and
  • U. Rajendra Acharya

Parkinson’s disease (PD) is globally the most common neurodegenerative movement disorder. It is characterized by a loss of dopaminergic neurons in the substantia nigra of the brain. However, current methods to diagnose PD on the basis of clinical fea...

  • Review
  • Open Access
14 Citations
4,943 Views
33 Pages

Exploring the Role of Ubiquitin-Proteasome System in the Pathogenesis of Parkinson’s Disease

  • Yiting Zhao,
  • Man Lin,
  • Fengguang Zhai,
  • Jun Chen and
  • Xiaofeng Jin

Parkinson’s disease (PD) is a prevalent neurodegenerative disorder among the elderly population. The pathogenesis of PD encompasses genetic alterations, environmental factors, and age-related neurodegenerative processes. Numerous studies have d...

  • Article
  • Open Access
923 Views
12 Pages

Ultrasonography of the Vagus Nerve in Parkinson’s Disease: Links to Clinical Profile and Autonomic Dysfunction

  • Ovidijus Laucius,
  • Justinas Drūteika,
  • Tadas Vanagas,
  • Renata Balnytė,
  • Andrius Radžiūnas and
  • Antanas Vaitkus

Background: Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by both motor and non-motor symptoms, including autonomic dysfunction. Structural alterations in the vagus nerve (VN) may contribute to PD pathophysi...

  • Review
  • Open Access
8 Citations
3,992 Views
28 Pages

Neurotrophins, particularly brain-derived neurotrophic factor (BDNF), act as key regulators of neuronal development, survival, and plasticity. BDNF is necessary for neuronal and functional maintenance in the striatum and the substantia nigra, both st...

  • Article
  • Open Access
2 Citations
2,649 Views
19 Pages

Quantifying Lenition as a Diagnostic Marker for Parkinson’s Disease and Atypical Parkinsonism

  • Ratree Wayland,
  • Rachel Meyer,
  • Ruhi Reddy,
  • Kevin Tang and
  • Karen W. Hegland

Objective: This study aimed to evaluate lenition, a phonological process involving consonant weakening, as a diagnostic marker for differentiating Parkinson’s Disease (PD) from Atypical Parkinsonism (APD). Early diagnosis is critical for optimi...

  • Article
  • Open Access
42 Citations
6,819 Views
29 Pages

Interplay of Ferritin Accumulation and Ferroportin Loss in Ageing Brain: Implication for Protein Aggregation in Down Syndrome Dementia, Alzheimer’s, and Parkinson’s Diseases

  • Animesh Alexander Raha,
  • Anwesha Biswas,
  • James Henderson,
  • Subhojit Chakraborty,
  • Anthony Holland,
  • Robert P. Friedland,
  • Elizabeta Mukaetova-Ladinska,
  • Shahid Zaman and
  • Ruma Raha-Chowdhury

19 January 2022

Iron accumulates in the ageing brain and in brains with neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), and Down syndrome (DS) dementia. However, the mechanisms of ir...

  • Article
  • Open Access
5 Citations
2,633 Views
25 Pages

Steady Moderate Exercise Confers Resilience Against Neurodegeneration and Neuroinflammation in a Mouse Model of Parkinson’s Disease

  • Ewelina Palasz,
  • Anna Gasiorowska-Bien,
  • Patrycja Drapich,
  • Wiktor Niewiadomski and
  • Grazyna Niewiadomska

28 January 2025

Intensive aerobic exercise slows the progression of movement disorders in Parkinson’s disease (PD) and is therefore recommended as an important component of treatment for PD patients. Studies in animal models of PD have shown that vigorous exer...

  • Review
  • Open Access
11 Citations
6,925 Views
20 Pages

Small Molecules in Parkinson’s Disease Therapy: From Dopamine Pathways to New Emerging Targets

  • Hwayoung Lee,
  • Ahmed Elkamhawy,
  • Polina Rakhalskaya,
  • Qili Lu,
  • Hossam Nada,
  • Guofeng Quan and
  • Kyeong Lee

14 December 2024

Parkinson’s disease (PD) is a chronic, progressive neurological disorder affecting approximately 10 million people worldwide, with prevalence expected to rise as the global population ages. It is characterized by the degeneration of dopamine-pr...

  • Review
  • Open Access
21 Citations
7,612 Views
23 Pages

Targeting New Candidate Genes by Small Molecules Approaching Neurodegenerative Diseases

  • Hueng-Chuen Fan,
  • Ching-Shiang Chi,
  • Shin-Nan Cheng,
  • Hsiu-Fen Lee,
  • Jeng-Dau Tsai,
  • Shinn-Zong Lin and
  • Horng-Jyh Harn

Neurodegenerative diseases (NDs) are among the most feared of the disorders that afflict humankind for the lack of specific diagnostic tests and effective treatments. Understanding the molecular, cellular, biochemical changes of NDs may hold therapeu...

  • Review
  • Open Access
80 Citations
23,193 Views
35 Pages

17 March 2009

Parkinson’s disease (PD) is the second most common progressive neurodegenerative disorder after Alzheimer's disease (AD) and represents a large health burden to society. Genetic and oxidative risk factors have been proposed as possible causes, but th...

  • Article
  • Open Access
1,824 Views
20 Pages

The Determination of Trimethylamine N-Oxide and Organic Acids Connected with Gut Microbiota in the Urine of Parkinson’s Disease Patients: A Pilot Study

  • Paulina Gątarek,
  • Małgorzata Pawełczyk,
  • Barbara Bobrowska-Korczaka,
  • Joanna Giebułtowicz,
  • Andrzej Głąbiński and
  • Joanna Kałużna-Czaplińska

Parkinson’s disease (PD) progression appears closely tied to gut microbiota alterations, with microbial metabolites potentially influencing neurodegeneration. This pilot study employed GC-MS and LC-MS/MS to analyze the urinary levels of gut-der...

  • Article
  • Open Access
16 Citations
3,974 Views
23 Pages

Kunitz-Type Peptides from Sea Anemones Protect Neuronal Cells against Parkinson’s Disease Inductors via Inhibition of ROS Production and ATP-Induced P2X7 Receptor Activation

  • Aleksandra Kvetkina,
  • Evgeny Pislyagin,
  • Ekaterina Menchinskaya,
  • Ekaterina Yurchenko,
  • Rimma Kalina,
  • Sergei Kozlovskiy,
  • Leonid Kaluzhskiy,
  • Alexander Menshov,
  • Natalia Kim and
  • Dmitry Aminin
  • + 5 authors

Parkinson’s disease (PD) is a socially significant disease, during the development of which oxidative stress and inflammation play a significant role. Here, we studied the neuroprotective effects of four Kunitz-type peptides from Heteractis cri...

  • Article
  • Open Access
2 Citations
2,372 Views
12 Pages

Cognitive Impairment Classification Prediction Model Using Voice Signal Analysis

  • Sang-Ha Sung,
  • Soongoo Hong,
  • Jong-Min Kim,
  • Do-Young Kang,
  • Hyuntae Park and
  • Sangjin Kim

13 September 2024

As the population ages, Alzheimer’s disease (AD) and Parkinson’s disease (PD) are increasingly common neurodegenerative diseases among the elderly. Human voice signals contain various characteristics, and the voice recording signals with...

  • Systematic Review
  • Open Access
1 Citations
3,856 Views
11 Pages

Mild Traumatic Brain Injury as a Risk Factor for Parkinsonism, Tics, and Akathisia: A Systematic Review and Meta-Analysis

  • Nashaba Khan,
  • Laura Romila,
  • Alin Ciobica,
  • Vasile Burlui,
  • Fatima Zahra Kamal and
  • Ioannis Mavroudis

25 December 2023

This meta-analysis aimed to assess the association between mild traumatic brain injury (mTBI) and the risk of developing Parkinsonism. A systematic literature review was conducted using PubMed, Embase, and Cochrane Library databases. Studies were eli...

  • Review
  • Open Access
409 Citations
30,538 Views
23 Pages

BDNF as a Promising Therapeutic Agent in Parkinson’s Disease

  • Ewelina Palasz,
  • Adrianna Wysocka,
  • Anna Gasiorowska,
  • Malgorzata Chalimoniuk,
  • Wiktor Niewiadomski and
  • Grazyna Niewiadomska

10 February 2020

Brain-derived neurotrophic factor (BDNF) promotes neuroprotection and neuroregeneration. In animal models of Parkinson’s disease (PD), BDNF enhances the survival of dopaminergic neurons, improves dopaminergic neurotransmission and motor perform...

  • Article
  • Open Access
6 Citations
3,426 Views
16 Pages

19 April 2025

The clinical diagnosis of Parkinson’s disease (PD) primarily relies on clinician-administered observational assessment tools, such as the Unified Parkinson’s Disease Rating Scale (UPDRS). However, these approaches are significantly influe...

  • Systematic Review
  • Open Access
17 Citations
4,927 Views
32 Pages

How Well Do Rodent Models of Parkinson’s Disease Recapitulate Early Non-Motor Phenotypes? A Systematic Review

  • Tracy D. Zhang,
  • Scott C. Kolbe,
  • Leah C. Beauchamp,
  • Ella K. Woodbridge,
  • David I. Finkelstein and
  • Emma L. Burrows

24 November 2022

The prodromal phase of Parkinson’s disease (PD) is characterised by many non-motor symptoms, and these have recently been posited to be predictive of later diagnosis. Genetic rodent models can develop non-motor phenotypes, providing tools to id...

  • Article
  • Open Access
8 Citations
2,527 Views
18 Pages

Meta-Analysis of the Mechanisms Underlying COVID-19 Modulation of Parkinson’s Disease

  • Jonathan Zhang,
  • Muhammed Bishir,
  • Sharman Barbhuiya and
  • Sulie L. Chang

31 August 2023

Coronavirus disease-19 (COVID-19) is caused by the infection of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). The virus enters host cells through receptor-mediated endocytosis of angiotensin-converting enzyme-2 (ACE2), leading to syst...

  • Article
  • Open Access
1,459 Views
21 Pages

25 September 2025

Parkinson’s disease (PD) is a neurodegenerative disease that is closely related to genetic and environmental factors, among which pesticide exposure is considered an important risk factor. Fresh jujube and hawthorn, as widely consumed fruits, m...

of 77